08 Sep Stemina Prepares for Commercialization
Stemina Biomarker Discovery is preparing to go to market in early 2018 with its autism diagnostic test panel, the company announced recently.
According to a release, Heiner Dreismann, the former head of Roche Molecular Diagnostics, has joined Stemina’s board of directors to help with the commercialization strategy.
Sorry, the comment form is closed at this time.